242 related articles for article (PubMed ID: 22733437)
1. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2013 Aug; 34(4):2109-17. PubMed ID: 23580180
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of metastasis-related tumor markers in colorectal cancer].
Wan XB; Pan ZZ; Ren YK; Ding PR; Chen G; Wan DS
Ai Zheng; 2009 Sep; 28(9):950-4. PubMed ID: 19728913
[TBL] [Abstract][Full Text] [Related]
4. CD44V6 expression in human colorectal carcinoma.
Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
[TBL] [Abstract][Full Text] [Related]
5. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence.
Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M
BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
[TBL] [Abstract][Full Text] [Related]
7. Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma.
Hara T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2019 Mar; 26(3):899-906. PubMed ID: 30610559
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
9. Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.
Chen L; Jiang B; Wang Z; Liu M; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
Clin Transl Oncol; 2014 Mar; 16(3):285-92. PubMed ID: 23860725
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of CD44 variants expression in colorectal cancer.
Li XD; Ji M; Wu J; Jiang JT; Wu CP
Tumori; 2013; 99(1):88-92. PubMed ID: 23549006
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma.
Chatzizacharias NA; Giaginis C; Gatzidou E; Tsourouflis G; Sfiniadakis I; Alexandrou P; Theocharis SE
Pathol Oncol Res; 2011 Jun; 17(2):277-85. PubMed ID: 21058027
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer: A meta-analysis.
Zhou W; Jiang C; Zhan N; Lv X; Fan L; Ninu M
J Cancer Res Ther; 2018; 14(Supplement):S28-S35. PubMed ID: 29578146
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
16. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
[TBL] [Abstract][Full Text] [Related]
17. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
18. Mortality association of enhanced CD44v6 expression is not mediated through occult lymphatic spread in stage II colorectal cancer.
Clarke G; Ryan E; O'Keane JC; Crowe J; Mathúna PM
J Gastroenterol Hepatol; 2000 Sep; 15(9):1028-31. PubMed ID: 11059932
[TBL] [Abstract][Full Text] [Related]
19. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
[TBL] [Abstract][Full Text] [Related]
20. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
Shi J; Zhou Z; Di W; Li N
BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
